Adverse events696

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 696

Download this page as JSON

Type	Event	Organ system	Group	Affected	At risk	Events
other	Conjunctival haemorrhage	Eye disorders	Arm A: Faricimab Q4W (Part 1)	10	365	11
other	Conjunctival haemorrhage	Eye disorders	Arm B: Aflibercept Q4W (Part 1)	14	361	14
other	Conjunctival haemorrhage	Eye disorders	Arm A: Faricimab Q4W to Faricimab PTI (Part 2)	10	359	11
other	Conjunctival haemorrhage	Eye disorders	Arm B: Aflibercept Q4W to Faricimab PTI (Part 2)	7	342	8
other	Vitreous detachment	Eye disorders	Arm A: Faricimab Q4W (Part 1)	11	365	11
other	Vitreous detachment	Eye disorders	Arm B: Aflibercept Q4W (Part 1)	9	361	9
other	Vitreous detachment	Eye disorders	Arm A: Faricimab Q4W to Faricimab PTI (Part 2)	6	359	6
other	Vitreous detachment	Eye disorders	Arm B: Aflibercept Q4W to Faricimab PTI (Part 2)	14	342	14
other	COVID-19	Infections and infestations	Arm A: Faricimab Q4W (Part 1)	14	365	14
other	COVID-19	Infections and infestations	Arm B: Aflibercept Q4W (Part 1)	12	361	12
other	COVID-19	Infections and infestations	Arm A: Faricimab Q4W to Faricimab PTI (Part 2)	42	359	42
other	COVID-19	Infections and infestations	Arm B: Aflibercept Q4W to Faricimab PTI (Part 2)	46	342	46
other	Intraocular pressure increased	Investigations	Arm A: Faricimab Q4W (Part 1)	9	365	11
other	Intraocular pressure increased	Investigations	Arm B: Aflibercept Q4W (Part 1)	12	361	22
other	Intraocular pressure increased	Investigations	Arm A: Faricimab Q4W to Faricimab PTI (Part 2)	16	359	21
other	Intraocular pressure increased	Investigations	Arm B: Aflibercept Q4W to Faricimab PTI (Part 2)	15	342	34
other	Hypertension	Vascular disorders	Arm A: Faricimab Q4W (Part 1)	15	365	15
other	Hypertension	Vascular disorders	Arm B: Aflibercept Q4W (Part 1)	10	361	10
other	Hypertension	Vascular disorders	Arm A: Faricimab Q4W to Faricimab PTI (Part 2)	12	359	13
other	Hypertension	Vascular disorders	Arm B: Aflibercept Q4W to Faricimab PTI (Part 2)	8	342	8

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04740931/events

API reference For AI assistants

Adverse events696

Sources 3

Read this list from software.